QuidelOrtho Corporation (NASDAQ: QDEL) Stock Competitors & Peer Comparison
See QDEL's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Specialties Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for QDEL and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| QDEL | $13.48 | -4.26% | 923.7M | 10.05 | $1.34 | N/A |
| ALC | $70.63 | +4.75% | 34.1B | 22.21 | $3.18 | +0.51% |
| STE | $232.22 | +4.85% | 22.6B | 22.27 | $10.42 | +1.12% |
| MLAB | $129.10 | -0.08% | 720.5M | 12.99 | $9.91 | +0.50% |
| MASS | $11.35 | -3.81% | 468.3M | -18.88 | -$0.60 | N/A |
| BWAY | $11.44 | -4.51% | 447.9M | 29.01 | $0.39 | N/A |
| SI | $19.75 | +2.12% | 411.4M | -11.42 | -$1.73 | N/A |
| MOBI | $10.58 | +9.75% | 352.9M | -3.58 | -$2.96 | N/A |
| ANIK | $21.09 | +2.38% | 282.2M | 43.04 | $0.49 | N/A |
| LAB | $0.64 | -2.22% | 249.5M | -9.08 | -$0.07 | N/A |
Stock Comparison
Alcon Inc. (NYSE: ALC)
QDEL vs ALC Comparison October 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 923.7M. In comparison, ALC has a market cap of 34.1B. Regarding current trading prices, QDEL is priced at $13.48 on the NASDAQ, while ALC trades at $70.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.05, whereas ALC's P/E ratio is 22.21. In terms of profitability, QDEL's ROE is -0.55%, compared to ALC's ROE of +0.03%. Regarding short-term risk, QDEL is more volatile compared to ALC. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check ALC's competition here
STERIS plc (NYSE: STE)
QDEL vs STE Comparison October 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 923.7M. In comparison, STE has a market cap of 22.6B. Regarding current trading prices, QDEL is priced at $13.48 on the NASDAQ, while STE trades at $232.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.05, whereas STE's P/E ratio is 22.27. In terms of profitability, QDEL's ROE is -0.55%, compared to STE's ROE of +0.11%. Regarding short-term risk, QDEL is more volatile compared to STE. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check STE's competition here
Mesa Laboratories, Inc. (NASDAQ: MLAB)
QDEL vs MLAB Comparison October 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 923.7M. In comparison, MLAB has a market cap of 720.5M. Regarding current trading prices, QDEL is priced at $13.48 on the NASDAQ, while MLAB trades at $129.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.05, whereas MLAB's P/E ratio is 12.99. In terms of profitability, QDEL's ROE is -0.55%, compared to MLAB's ROE of +0.03%. Regarding short-term risk, QDEL is more volatile compared to MLAB. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check MLAB's competition here
908 Devices Inc. (NASDAQ: MASS)
QDEL vs MASS Comparison October 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 923.7M. In comparison, MASS has a market cap of 468.3M. Regarding current trading prices, QDEL is priced at $13.48 on the NASDAQ, while MASS trades at $11.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.05, whereas MASS's P/E ratio is -18.88. In terms of profitability, QDEL's ROE is -0.55%, compared to MASS's ROE of -0.25%. Regarding short-term risk, QDEL is more volatile compared to MASS. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check MASS's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
QDEL vs BWAY Comparison October 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 923.7M. In comparison, BWAY has a market cap of 447.9M. Regarding current trading prices, QDEL is priced at $13.48 on the NASDAQ, while BWAY trades at $11.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.05, whereas BWAY's P/E ratio is 29.01. In terms of profitability, QDEL's ROE is -0.55%, compared to BWAY's ROE of +0.13%. Regarding short-term risk, QDEL is more volatile compared to BWAY. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check BWAY's competition here
Shoulder Innovations, Inc. (NYSE: SI)
QDEL vs SI Comparison October 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 923.7M. In comparison, SI has a market cap of 411.4M. Regarding current trading prices, QDEL is priced at $13.48 on the NASDAQ, while SI trades at $19.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.05, whereas SI's P/E ratio is -11.42. In terms of profitability, QDEL's ROE is -0.55%, compared to SI's ROE of -0.26%. Regarding short-term risk, QDEL is more volatile compared to SI. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check SI's competition here
Mobia Medical, Inc. Common Stock (NASDAQ: MOBI)
QDEL vs MOBI Comparison October 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 923.7M. In comparison, MOBI has a market cap of 352.9M. Regarding current trading prices, QDEL is priced at $13.48 on the NASDAQ, while MOBI trades at $10.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.05, whereas MOBI's P/E ratio is -3.58. In terms of profitability, QDEL's ROE is -0.55%, compared to MOBI's ROE of +0.80%. Regarding short-term risk, QDEL is less volatile compared to MOBI. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check MOBI's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
QDEL vs ANIK Comparison October 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 923.7M. In comparison, ANIK has a market cap of 282.2M. Regarding current trading prices, QDEL is priced at $13.48 on the NASDAQ, while ANIK trades at $21.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.05, whereas ANIK's P/E ratio is 43.04. In terms of profitability, QDEL's ROE is -0.55%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, QDEL is more volatile compared to ANIK. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check ANIK's competition here
Standard BioTools Inc. (NASDAQ: LAB)
QDEL vs LAB Comparison October 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 923.7M. In comparison, LAB has a market cap of 249.5M. Regarding current trading prices, QDEL is priced at $13.48 on the NASDAQ, while LAB trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.05, whereas LAB's P/E ratio is -9.08. In terms of profitability, QDEL's ROE is -0.55%, compared to LAB's ROE of -0.18%. Regarding short-term risk, QDEL is more volatile compared to LAB. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check LAB's competition here
Edap Tms S.a. (NASDAQ: EDAP)
QDEL vs EDAP Comparison October 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 923.7M. In comparison, EDAP has a market cap of 178.2M. Regarding current trading prices, QDEL is priced at $13.48 on the NASDAQ, while EDAP trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.05, whereas EDAP's P/E ratio is -5.80. In terms of profitability, QDEL's ROE is -0.55%, compared to EDAP's ROE of -3.13%. Regarding short-term risk, QDEL is more volatile compared to EDAP. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check EDAP's competition here
Trinity Biotech plc (NASDAQ: TRIB)
QDEL vs TRIB Comparison October 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 923.7M. In comparison, TRIB has a market cap of 160.2M. Regarding current trading prices, QDEL is priced at $13.48 on the NASDAQ, while TRIB trades at $7.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.05, whereas TRIB's P/E ratio is -0.13. In terms of profitability, QDEL's ROE is -0.55%, compared to TRIB's ROE of +0.49%. Regarding short-term risk, QDEL is more volatile compared to TRIB. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check TRIB's competition here
Apyx Medical Corporation (NASDAQ: APYX)
QDEL vs APYX Comparison October 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 923.7M. In comparison, APYX has a market cap of 100.7M. Regarding current trading prices, QDEL is priced at $13.48 on the NASDAQ, while APYX trades at $2.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.05, whereas APYX's P/E ratio is -11.95. In terms of profitability, QDEL's ROE is -0.55%, compared to APYX's ROE of -0.79%. Regarding short-term risk, QDEL is more volatile compared to APYX. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check APYX's competition here
Nyxoah S.A. (NASDAQ: NYXH)
QDEL vs NYXH Comparison October 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 923.7M. In comparison, NYXH has a market cap of 83.2M. Regarding current trading prices, QDEL is priced at $13.48 on the NASDAQ, while NYXH trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.05, whereas NYXH's P/E ratio is -0.32. In terms of profitability, QDEL's ROE is -0.55%, compared to NYXH's ROE of -1.80%. Regarding short-term risk, QDEL is more volatile compared to NYXH. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check NYXH's competition here
SkinHealth Systems Inc. (NASDAQ: SKIN)
QDEL vs SKIN Comparison October 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 923.7M. In comparison, SKIN has a market cap of 73.6M. Regarding current trading prices, QDEL is priced at $13.48 on the NASDAQ, while SKIN trades at $11.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.05, whereas SKIN's P/E ratio is -51.41. In terms of profitability, QDEL's ROE is -0.55%, compared to SKIN's ROE of -0.48%. Regarding short-term risk, QDEL is more volatile compared to SKIN. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check SKIN's competition here
Spectral AI, Inc. (NASDAQ: MDAI)
QDEL vs MDAI Comparison October 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 923.7M. In comparison, MDAI has a market cap of 48.3M. Regarding current trading prices, QDEL is priced at $13.48 on the NASDAQ, while MDAI trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.05, whereas MDAI's P/E ratio is -3.33. In terms of profitability, QDEL's ROE is -0.55%, compared to MDAI's ROE of +1.21%. Regarding short-term risk, QDEL is more volatile compared to MDAI. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check MDAI's competition here
DarioHealth Corp. (NASDAQ: DRIO)
QDEL vs DRIO Comparison October 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 923.7M. In comparison, DRIO has a market cap of 33.4M. Regarding current trading prices, QDEL is priced at $13.48 on the NASDAQ, while DRIO trades at $3.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.05, whereas DRIO's P/E ratio is -0.58. In terms of profitability, QDEL's ROE is -0.55%, compared to DRIO's ROE of +1.04%. Regarding short-term risk, QDEL is less volatile compared to DRIO. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check DRIO's competition here
HeartBeam, Inc. (NASDAQ: BEAT)
QDEL vs BEAT Comparison October 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 923.7M. In comparison, BEAT has a market cap of 22.5M. Regarding current trading prices, QDEL is priced at $13.48 on the NASDAQ, while BEAT trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.05, whereas BEAT's P/E ratio is -0.78. In terms of profitability, QDEL's ROE is -0.55%, compared to BEAT's ROE of -6.87%. Regarding short-term risk, QDEL is more volatile compared to BEAT. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check BEAT's competition here
iTonic Holdings Ltd. (NASDAQ: ITOC)
QDEL vs ITOC Comparison October 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 923.7M. In comparison, ITOC has a market cap of 22.1M. Regarding current trading prices, QDEL is priced at $13.48 on the NASDAQ, while ITOC trades at $3.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.05, whereas ITOC's P/E ratio is -0.77. In terms of profitability, QDEL's ROE is -0.55%, compared to ITOC's ROE of -0.60%. Regarding short-term risk, QDEL is less volatile compared to ITOC. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check ITOC's competition here
Spectral AI, Inc. (NASDAQ: MDAIW)
QDEL vs MDAIW Comparison October 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 923.7M. In comparison, MDAIW has a market cap of 13.6M. Regarding current trading prices, QDEL is priced at $13.48 on the NASDAQ, while MDAIW trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.05, whereas MDAIW's P/E ratio is -1.20. In terms of profitability, QDEL's ROE is -0.55%, compared to MDAIW's ROE of N/A. Regarding short-term risk, QDEL is less volatile compared to MDAIW. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check MDAIW's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
QDEL vs BEATW Comparison October 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 923.7M. In comparison, BEATW has a market cap of 8.3M. Regarding current trading prices, QDEL is priced at $13.48 on the NASDAQ, while BEATW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.05, whereas BEATW's P/E ratio is -0.02. In terms of profitability, QDEL's ROE is -0.55%, compared to BEATW's ROE of -6.87%. Regarding short-term risk, QDEL is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check BEATW's competition here
QTREX Quantum Ltd. Warrant (NASDAQ: QTEXW)
QDEL vs QTEXW Comparison October 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 923.7M. In comparison, QTEXW has a market cap of 3.5M. Regarding current trading prices, QDEL is priced at $13.48 on the NASDAQ, while QTEXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.05, whereas QTEXW's P/E ratio is -0.01. In terms of profitability, QDEL's ROE is -0.55%, compared to QTEXW's ROE of N/A. Regarding short-term risk, QDEL is less volatile compared to QTEXW. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check QTEXW's competition here
WORK Medical Technology Group Ltd. Class A (NASDAQ: WOK)
QDEL vs WOK Comparison October 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 923.7M. In comparison, WOK has a market cap of 2.7M. Regarding current trading prices, QDEL is priced at $13.48 on the NASDAQ, while WOK trades at $1.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.05, whereas WOK's P/E ratio is N/A. In terms of profitability, QDEL's ROE is -0.55%, compared to WOK's ROE of -0.19%. Regarding short-term risk, QDEL is more volatile compared to WOK. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check WOK's competition here
ENvue Medical, Inc. (NASDAQ: FEED)
QDEL vs FEED Comparison October 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 923.7M. In comparison, FEED has a market cap of 951.4K. Regarding current trading prices, QDEL is priced at $13.48 on the NASDAQ, while FEED trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.05, whereas FEED's P/E ratio is -0.15. In terms of profitability, QDEL's ROE is -0.55%, compared to FEED's ROE of -0.60%. Regarding short-term risk, QDEL is less volatile compared to FEED. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check FEED's competition here
Tivic Health Systems, Inc. (NASDAQ: TIVC)
QDEL vs TIVC Comparison October 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 923.7M. In comparison, TIVC has a market cap of 279.2K. Regarding current trading prices, QDEL is priced at $13.48 on the NASDAQ, while TIVC trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.05, whereas TIVC's P/E ratio is -0.04. In terms of profitability, QDEL's ROE is -0.55%, compared to TIVC's ROE of -1.65%. Regarding short-term risk, QDEL is less volatile compared to TIVC. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check TIVC's competition here